ENDRA Life Sciences Inc. (NDRA) Return on equity 2017–2020
ENDRA Life Sciences Inc. (NDRA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-163.6%FY2020 · since FY2017: -101.9% → -163.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | -163.6% | +115.9 pp |
| FY2019 | -279.5% | -122.7 pp |
| FY2018 | -156.8% | -54.9 pp |
| FY2017 | -101.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice